Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 29, 2024 4:00 P.M.
Form: F-3
CIK: 0001722926
Company Name: ASLAN Pharmaceuticals Ltd
File Number: 333-278217